Literature DB >> 17244891

Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats.

R Schneider1, C Sauvant, B Betz, M Otremba, D Fischer, H Holzinger, C Wanner, J Galle, M Gekle.   

Abstract

Ischemic acute renal failure (iARF) was described to reduce renal extraction of the organic anion para-aminohippurate (PAH) in humans. The rate-limiting step of renal organic anion secretion is its basolateral uptake into proximal tubular cells. This process is mediated by the organic anion transporters OAT1 and OAT3, which both have a broad spectrum of substrates including a variety of pharmaceutics and toxins. Using a rat model of iARF, we investigated whether impairing the secretion of the organic anion PAH might be associated with downregulation of OAT1 or OAT3. Inulin and PAH clearance was determined starting from 6 up to 336 h after ischemia-reperfusion (I/R) injury. Net secretion of PAH was calculated and OAT1 as well as OAT3 expression was analyzed by RT-PCR and Western blotting. Inulin and PAH clearance along with PAH net secretion were initially diminished after I/R injury with a gradual recovery during follow-up. This initial impairment after iARF was accompanied by decreased mRNA and protein levels of OAT1 and OAT3 in clamped animals compared with sham-operated controls. In correlation to the improvement of kidney function, both mRNA and protein levels of OAT1 and OAT3 were upregulated during the follow-up. Thus decreased expression of OAT1 and OAT3 is sufficient to explain the decline of PAH secretion after iARF. As a result, this may have substantial impact on excretion kinetics and half-life of organic anions. As a consequence, the biological effects of a variety of organic anions may be affected after iARF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244891     DOI: 10.1152/ajprenal.00473.2006

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  31 in total

1.  Hepatic sulfotransferase as a nephropreventing target by suppression of the uremic toxin indoxyl sulfate accumulation in ischemic acute kidney injury.

Authors:  Hideyuki Saito; Misato Yoshimura; Chika Saigo; Megumi Komori; Yui Nomura; Yuko Yamamoto; Masataka Sagata; Ayaka Wakida; Erina Chuman; Kazuhiko Nishi; Hirofumi Jono
Journal:  Toxicol Sci       Date:  2014-06-23       Impact factor: 4.849

Review 2.  Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.

Authors:  Michael Murray; Fanfan Zhou
Journal:  Br J Pharmacol       Date:  2017-04-24       Impact factor: 8.739

Review 3.  Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease.

Authors:  Li Wang; Douglas H Sweet
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

Review 4.  Roles of organic anion/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins.

Authors:  Ken-ichi Hosoya; Masanori Tachikawa
Journal:  Clin Exp Nephrol       Date:  2011-05-25       Impact factor: 2.801

5.  Mutational analysis of the role of GXXXG motif in the function of human organic anion transporter 1 (hOAT1).

Authors:  Peng Duan; Jinwei Wu; Guofeng You
Journal:  Int J Biochem Mol Biol       Date:  2011-01-01

6.  Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.

Authors:  Kevin T Bush; Prabhleen Singh; Sanjay K Nigam
Journal:  JCI Insight       Date:  2020-04-09

7.  Exhaustive exercise decreases renal organic anion transporter 3 function.

Authors:  Tipwadee Bunprajun; Chaowalit Yuajit; Rattikarn Noitem; Varanuj Chatsudthipong
Journal:  J Physiol Sci       Date:  2018-10-03       Impact factor: 2.781

Review 8.  Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.

Authors:  Sun-Young Ahn; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2009-06-10       Impact factor: 4.436

9.  Hypoxia alters ocular drug transporter expression and activity in rat and calf models: implications for drug delivery.

Authors:  Rajendra S Kadam; Preveen Ramamoorthy; Daniel J LaFlamme; Timothy A McKinsey; Uday B Kompella
Journal:  Mol Pharm       Date:  2013-05-22       Impact factor: 4.939

10.  Oat5 and NaDC1 protein abundance in kidney and urine after renal ischemic reperfusion injury.

Authors:  Gisela Di Giusto; Naohiko Anzai; Hitoshi Endou; Adriana M Torres
Journal:  J Histochem Cytochem       Date:  2008-09-15       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.